Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Magnesium glycerophosphate (magnesium 97.2mg/5ml (4mmol/5ml)) oral suspension (Special Order) |
| BNF code | 0905013G0AACZCZ |
| Virtual Medicinal Product | Magnesium glycerophosphate (magnesium 97.2mg/5ml (4mmol/5ml)) oral suspension |
| Name | Magnesium glycerophosphate (magnesium 97.2mg/5ml (4mmol/5ml)) oral suspension |
| Abbreviated name | Mag glycerophos (mag 97.2mg/5ml (4mmol/5ml)) susp |
| Date of name applicability | 26 Apr 2010 |
| Previous name | Magnesium glycerophosphate 97.2mg/5ml oral suspension |
| Supplier | Special Order |
| Current licensing authority | None |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | Special |
| Actual Medicinal Product Packs | |
|---|---|
| Magnesium glycerophosphate (magnesium 97.2mg/5ml (4mmol/5ml)) oral suspension (Special Order) 100 ml | |
| Magnesium glycerophosphate (magnesium 97.2mg/5ml (4mmol/5ml)) oral suspension (Special Order) 1 ml | |
dm+d data retrieved from TRUD: release NHSBSA_2.0.0_20250203000001, imported on 4th February 2025 at 03:53:58.